19/12/2022
We're delighted to have assisted Shield Therapeutics plc with shareholder documentation for its incredibly successful - upsized twice and still oversubscribed! - US$18.5m fundraising by means of a placing and open offer of up to £3.9m. Congratulations to the company and its advisors Taylor Wessing and finnCap Group on this great achievement!
Other recent news
01/04/2025
Why is branding so important in IPO investor communications?
31/03/2025
Power rangers: helping Elia Group with its €1.35bn Rights Offeri…
26/03/2025
Mastering the IPO journey: join the LSE's webinar on Thursday 17…
18/03/2025